CVS Group, a UK veterinary group, piloted AI scribes for consultation notes in five referral hospitals and then extended them to 77 of its first-opinion practices

Event date / reported

Evidence stage

Tasks this bears on

Where this applies

A listed UK veterinary group describing its own practices; it uses the tools and does not sell them. In 2025 it piloted AI-assisted scribing, which captures structured consultation notes in real time: specialist clinicians in five referral hospitals tested two AI scribe platforms for three months, and positive feedback supported expansion into 77 first-opinion practices across the UK, with training on responsible use, consent and patient safety. The UK business has 423 practices, and elsewhere the same report still describes the work as trialling AI scribe for clinical and outpatient notes, so this is recorded as a pilot. It gives no figures for time saved, note quality or how often clinicians correct the notes.

What this means

What it does not yet show

It is one group's account, still described partly as a trial, with no figures on time saved or on how often the notes need correcting; it says nothing about vet or support-staff numbers.

What you can check

Does it change the assessment?

Source